Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Scientific Reports (1)
Communications Biology (1)
Nature Cancer (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Immunology
Microbiology
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Anna H. Turaj Clear advanced filters

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Lim and colleagues present the UK PROSECO study where they assess humoral and cellular immune responses to one, two and three doses of vaccination against SARS-CoV-2 in patients with B-cell malignancies in a prospective observational study.

Sean H. Lim
Beth Stuart
David Goldblatt
ResearchOpen Access24 Mar 2022
Nature Cancer

Volume: 3, P: 552-564
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering

Agonistic CD27 monoclonal antibodies can be used to enhance the efficacy of depleting antibodies such as anti-CTLA-4 in a colon adenocarcinoma tumour model. CD27 antibody agonism is dependent on isotype and epitope specificity.

Franziska Heckel
Anna H. Turaj
Sean H. Lim
ResearchOpen Access14 Mar 2022
Communications Biology

Volume: 5, P: 1-15
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking

Anna H. Turaj
Kerry L. Cox
Sean H. Lim
ResearchOpen Access02 Feb 2018
Scientific Reports

Volume: 8, P: 1-11